Mitopure Urolithin A

Dr. Anurag Singh discusses the MitoImmune trial published in Nature Aging showing urolithin A increased CD8 T-cells by 20% and enhanced immune clearance capacity in just 28 days. Learn why immune health may be the key to longevity. If you would like to support our channel please consider joining our Patreon https://patreon.com/ModernHealthspan ~~~~~~~~~~~~~~ Time-Line Mitopure Urolithin A, 10% off Code MODERN https://tidd.ly/4bLCpgu ~~~~~~~~~~~~~~ The MitoImmune trial, published in Nature Aging, studied 50 middle-aged adults for 28 days. Results showed urolithin A increased stem cell-like CD8 T-cells and boosted mitochondria in immune cells by 20%. Immune cells also showed enhanced clearance capacity against bacteria and viruses. Dr. Anurag Singh explains why the immune system is one of the first organs affected by aging, how mitochondrial decline impairs vaccine response in older adults, and the emerging field of immunometabolism. He discusses ongoing trials combining urolithin A with cancer immunotherapy checkpoint inhibitors and future studies on vaccination response. If you're concerned about immune aging, infection susceptibility, or maintaining immune function as you age, this video reveals why mitochondrial health in immune cells may be the foundation of healthy aging. 🔢Chapters 0:00 Introduction to MitoImmune Trial 2:37 Trial Results: 20% More Mitochondria in CD8 T-Cells 4:42 Why Fatty Acid Oxidation Matters for Immune Cells 6:47 Why Immune Health is Key to Longevity 10:05 Future Trials: Cancer and Vaccination Response 🌐Links in this video Time-Line home page https://www.timeline.com/ ATLAS Trial: Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults https://pubmed.ncbi.nlm.nih.gov/35584623/ Effect of the mitophagy inducer urolithin A on age-related immune decline: a randomized, placebo-controlled trial https://www.nature.com/articles/s43587-025-00996-x #ImmuneAging #CD8TCells #Immunometabolism